CE: Pediatric Antibiotic Stewardship

Amanda Good1, Rita Olans

  • 1Amanda Good is a certified pediatric NP and a family medicine nurse at Charles River Community Health, Boston. Rita Olans is an associate professor at the MGH Institute of Health Professions, Boston. Contact author: Amanda Good, amanda.good.lynn@gmail.com . The authors and planners have disclosed no potential conflicts of interest, financial or otherwise. A podcast with the authors is available at www.ajnonline.com .

Insights

Reducing antibiotic duration in children is crucial for combating resistance and preventing adverse effects. Shorter treatment courses for common pediatric infections show promise, but more pediatric-specific research is needed.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Antimicrobial Stewardship

Background:

  • Antibiotic resistance is a growing concern, with most prescriptions originating in ambulatory settings.
  • Pediatric antibiotic prescription rates are highest in young children, and early use is linked to health risks.
  • Current antimicrobial stewardship often focuses on prescribing, neglecting antibiotic therapy duration.

Purpose of the Study:

  • To highlight the critical, yet underexamined, role of antibiotic therapy duration in pediatric antimicrobial stewardship.
  • To advocate for evidence-based reduction in antibiotic treatment courses for common pediatric infections.

Main Methods:

  • Review of existing research on antibiotic therapy duration in pediatrics.
  • Analysis of limitations in current pediatric antibiotic duration studies, including reliance on adult data and industry influence.

Main Results:

  • Many common pediatric infections may be safely and effectively treated with shorter antibiotic courses.
  • Reduced antibiotic duration can decrease antibiotic resistance and prevent adverse treatment effects.

Conclusions:

  • Current pediatric antibiotic duration recommendations often lack strong scientific evidence.
  • Further pediatric-specific research is essential to establish optimal, evidence-based antibiotic treatment durations.
  • Overcoming challenges like reliance on adult data and clinician hesitancy is vital for advancing pediatric antimicrobial stewardship.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...